Team:Uppsala/human-practice

From 2013.igem.org

(Difference between revisions)
 
(22 intermediate revisions not shown)
Line 13: Line 13:
</style>
</style>
 +
 +
<script type="text/javascript">
 +
function preloadimages(arr){
 +
    var newimages=[]
 +
    var arr=(typeof arr!="object")? [arr] : arr //force arr parameter to always be an array
 +
    for (var i=0; i<arr.length; i++){
 +
        newimages[i]=new Image()
 +
        newimages[i].src=arr[i]
 +
    }
 +
}
 +
 +
</script>
 +
 +
<script type="text/javascript">
 +
/*Acts once the document is loaded*/ $(document).ready(function() { /*Move the tn-main-wrap as child of <body>*/ $("#tn-main-wrap-wrap").prependTo($("body")); /*Move the menubars in the tn-main-wrap*/ $("#menubar.left-menu").appendTo($("#tn-main-wrap")); $("#menubar.right-menu").appendTo($("#tn-main-wrap"));
 +
/*Spoiler JS*/ $(".tn-spoiler div").slideUp(); $(".tn-spoiler a").click(function(e) { e.preventDefault(); $(".tn-spoiler-active").removeClass("tn-spoiler-active"); $(this).parent().addClass("tn-spoiler-active"); $(".tn-spoiler").not(".tn-spoiler-active").children("div").slideUp(); $(".tn-spoiler-active").children("div").slideToggle(); });
 +
/*Add favicon*/ $("link[rel='shortcut icon']").remove(); $("head").append("<link rel='shortcut icon' type='image/png' href='https://static.igem.org/mediawiki/2013/6/6d/Uppsalas-cow-con.png'>"); });
 +
</script>
</head>
</head>
Line 30: Line 48:
<div id="igem"><a href="https://2013.igem.org/Main_Page"><img class="igem" src="https://static.igem.org/mediawiki/2013/b/b8/Uppsala2013_Uppsala_IGEM_log_blue.png"></a></div>
<div id="igem"><a href="https://2013.igem.org/Main_Page"><img class="igem" src="https://static.igem.org/mediawiki/2013/b/b8/Uppsala2013_Uppsala_IGEM_log_blue.png"></a></div>
 +
 +
<img class="slogan" src="https://static.igem.org/mediawiki/2013/a/ad/Uppsala2013_Header.png">
</div>  
</div>  
Line 57: Line 77:
                                                 <li><a href="https://2013.igem.org/Team:Uppsala/metabolic-engineering">Metabolic engineering</a>
                                                 <li><a href="https://2013.igem.org/Team:Uppsala/metabolic-engineering">Metabolic engineering</a>
                                                     <ul>
                                                     <ul>
-
                                                                 <li><a href="https://2013.igem.org/Team:Uppsala/p-coumaric-acid">P-coumaric acid</a></li>
+
                                                                 <li><a href="https://2013.igem.org/Team:Uppsala/p-coumaric-acid">p-Coumaric acid</a></li>
                                                                 <li><a href="https://2013.igem.org/Team:Uppsala/resveratrol">Resveratrol</a></li>
                                                                 <li><a href="https://2013.igem.org/Team:Uppsala/resveratrol">Resveratrol</a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/lycopene">Lycopene</a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/lycopene">Lycopene</a></li>
Line 78: Line 98:
<li><a href="https://2013.igem.org/Team:Uppsala/modeling" id="list_type1"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/6/63/Uppsala2013_Modeling.png"></a>
<li><a href="https://2013.igem.org/Team:Uppsala/modeling" id="list_type1"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/6/63/Uppsala2013_Modeling.png"></a>
<ul>
<ul>
-
<li><a href="https://2013.igem.org/Team:Uppsala/P-Coumaric-acid-pathway">P-Coumaric acid</a></li>
+
<li><a href="https://2013.igem.org/Team:Uppsala/P-Coumaric-acid-pathway">Kinetic model</a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/modeling-tutorial">Modeling tutorial </a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/modeling-tutorial">Modeling tutorial </a></li>
 +
 +
<li><a href="https://2013.igem.org/Team:Uppsala/toxicity-model">Toxicity model</a></li>
</ul></li>
</ul></li>
<li><a href="https://2013.igem.org/Team:Uppsala/parts" id="list_type2"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/e/eb/Uppsala2013_parts.png"></a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/parts" id="list_type2"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/e/eb/Uppsala2013_parts.png"></a></li>
Line 88: Line 110:
<li><a href="https://2013.igem.org/Team:Uppsala/carotenoid-group">Carotenoid group</a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/carotenoid-group">Carotenoid group</a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/chassi-group">Chassi group</a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/chassi-group">Chassi group</a></li>
 +
                                                <li><a href="https://2013.igem.org/Team:Uppsala/advisors">Advisors</a></li>
</ul></li>
</ul></li>
Line 97: Line 120:
<li><a href="https://2013.igem.org/Team:Uppsala/public-opinion">Public opinion </a></li>
<li><a href="https://2013.igem.org/Team:Uppsala/public-opinion">Public opinion </a></li>
                                                 <li><a href="https://2013.igem.org/Team:Uppsala/Outreach">High school & media </a></li>
                                                 <li><a href="https://2013.igem.org/Team:Uppsala/Outreach">High school & media </a></li>
-
 
+
<li><a href="https://2013.igem.org/Team:Uppsala/bioart">BioArt</a></li>
 +
<li><a href="https://2013.igem.org/Team:Uppsala/LactonutritiousWorld">A LactoWorld</a></li>
 +
<li><a href="https://2013.igem.org/Team:Uppsala/killswitches">Killswitches</a></li>
 +
<li><a href="https://2013.igem.org/Team:Uppsala/realization">Patent</a></li>
</ul></li>
</ul></li>
-
<li><a href="https://2013.igem.org/Team:Uppsala/attribution" id="list_type4"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/5/5d/Uppsala2013_Attributions.png"></a>
+
<li><a href="https://2013.igem.org/Team:Uppsala/attribution" id="list_type4"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/5/5d/Uppsala2013_Attributions.png"></a></li>  
-
                                <ul>
+
-
                                    <li><a href="https://2013.igem.org/Team:Uppsala/collaboration">Collaboration</a></li>
+
-
                                </ul></li>  
+
<li><a href="https://2013.igem.org/Team:Uppsala/notebook" id="list_type3"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/3/36/Uppsala2013_Notebook.png"></a>
<li><a href="https://2013.igem.org/Team:Uppsala/notebook" id="list_type3"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/3/36/Uppsala2013_Notebook.png"></a>
                                     <ul>
                                     <ul>
                                         <li><a href="https://2013.igem.org/Team:Uppsala/safety-form">Safety form</a></li>
                                         <li><a href="https://2013.igem.org/Team:Uppsala/safety-form">Safety form</a></li>
 +
                                        <li><a href="https://2013.igem.org/Team:Uppsala/protocols">Protocols</a></li>
                                     </ul></li>
                                     </ul></li>
</ul>
</ul>
Line 114: Line 138:
<div id="main_content"> <!-- Put content here -->
<div id="main_content"> <!-- Put content here -->
 +
 +
<div class="HP_awesome_texting">
 +
<h1 class="main-title">Human practice</h1>
 +
 +
 +
 +
This year, when we decided on our iGEM project, one of our main focuses was that it should be well integrated with our human practice projects. We think that human practice is one of the most important parts of iGEM.
 +
<br><br>
 +
Our goal is to create GM food. To be able to realize our vision we have to consider alot of different aspects.
 +
<br><br>
 +
Is it safe to eat GM food?<br>
 +
Will people want to eat genetically engineered bacteria? <br>
 +
How can we easily communicate our project idea? <br>
 +
If we commercialize our idea, should we patent it? <br>
 +
Can we patent biobricks and do we even want that? <br>
 +
How should we see on safety issues, can our organism spread in the ecosystem? Should we add a killswitch? <br>
 +
Why is GMO restricted in Europe and what does politicians think of this? <br>
 +
<br>
 +
<b>Conclussion</b><br>
 +
We have tried to answer all of these questions in our human practice project. The conclussion we have made is that we think the future of GM food is bright and that it is absolutely realizable.
 +
 +
 +
 +
 +
 +
 +
</div>
 +
 +
<div class="hp_master_thing">
<div class="hp_master_thing">
<div id="bio_safty">
<div id="bio_safty">
Line 147: Line 200:
<div id="main_cow" >
<div id="main_cow" >
<img src="https://static.igem.org/mediawiki/2013/e/e8/Uppsala2013_pic1.png" name="imageTag" />
<img src="https://static.igem.org/mediawiki/2013/e/e8/Uppsala2013_pic1.png" name="imageTag" />
 +
 +
<div style="position: relative; top: -440px; left: 230px; width:100px; height: 100px; z-index: 1000;">
 +
<a href="https://2013.igem.org/Team:Uppsala/realization" style="display:block;height:100%;width:100%;"></a>
 +
</div>
 +
<div style="position: relative; top: -300px; left: -80px; width:250px; height: 200px;">
 +
<a href="https://2013.igem.org/Team:Uppsala/killswitches""><img src="https://static.igem.org/mediawiki/2013/4/4b/Uppsala_question1.png" style="width: 250px; "></a>'
 +
</div>
 +
<div style="position: relative; top: -450px; left: 250px; width:200px; height: 200px; ">
 +
<a href="https://2013.igem.org/Team:Uppsala/LactonutritiousWorld" > <img src="https://static.igem.org/mediawiki/2013/1/17/Uppsala_question2.png" style="width: 200px;"></a>
</div>
</div>
-
<div class="HP_awesome_texting">
+
 
-
<h1 class="main-title">The next generation of synthetic probiotics</h1>
+
 
-
    When we first set out to create this year's modelling contibution, we asked ourselves what we wanted from our project. None of us had much experience in the ways of modelling biological systems, so the first objective was to find inspiration for the project at hand. Naturally, the first place to look was the wikis of the teams that came before us. We wanted to see what other teams had accomplished, what they had brought to the table and perhaps what we thought could be improved in their modeling projects. After much searching, and more than a little contemplation, we arrived at the decision of making two different models, with two quite different goals.
+
<script type="text/javascript">
-
</div>
+
preloadimages(['https://static.igem.org/mediawiki/2013/9/98/Uppsala2013_pic2.png', 'https://static.igem.org/mediawiki/2013/9/9d/Uppsala2013_pic4.png', 'https://static.igem.org/mediawiki/2013/3/39/Uppsala2013_pic3.png', 'https://static.igem.org/mediawiki/2013/f/f4/Uppsala2013_pic6.png', 'https://static.igem.org/mediawiki/2013/4/43/Uppsala2013_pic5.png']);
 +
</script>
 +
</div>
 +
 
 +
 
</div>
</div>
Line 158: Line 224:
<div id="bottom-pic">
<div id="bottom-pic">
-
          <img src="https://static.igem.org/mediawiki/2013/a/aa/Bottom_picture.png" >
+
     
</div>
</div>

Latest revision as of 19:57, 27 October 2013

Human practice

This year, when we decided on our iGEM project, one of our main focuses was that it should be well integrated with our human practice projects. We think that human practice is one of the most important parts of iGEM.

Our goal is to create GM food. To be able to realize our vision we have to consider alot of different aspects.

Is it safe to eat GM food?
Will people want to eat genetically engineered bacteria?
How can we easily communicate our project idea?
If we commercialize our idea, should we patent it?
Can we patent biobricks and do we even want that?
How should we see on safety issues, can our organism spread in the ecosystem? Should we add a killswitch?
Why is GMO restricted in Europe and what does politicians think of this?

Conclussion
We have tried to answer all of these questions in our human practice project. The conclussion we have made is that we think the future of GM food is bright and that it is absolutely realizable.
'

Retrieved from "http://2013.igem.org/Team:Uppsala/human-practice"